Skip to main content

Lipid-Based Nanoparticles in Cosmetic and Pharmaceutical Products for the Skin

  • Chapter
  • First Online:
Bionanomaterials for Skin Regeneration

Part of the book series: SpringerBriefs in Bioengineering ((BRIEFSBIOENG))

  • 965 Accesses

Abstract

Topical delivery of drugs to the skin, for skin or for musculoskeletal conditions, is valued because it allows use of smaller loads of active ingredients to obtain the same effect as that obtained following oral or parenteral administration. This results in reduction of systemic side effects and avoidance of passage through the liver after intestinal absorption. The problems for this type of treatment are the possibility to control it, to evaluate the exact amount of active agent to reach each skin layer/target site, and most of all, to overcome the barrier represented by the (SC). This barrier, more efficient against hydrophilic species, allows absorption which ranges between 1 % of a dose of active (hydrocortisone) on the soles and 42 % when applied to the eyelids [1]. Moreover, in some skin diseases, due to a partially disturbed skin structure, the uptake of the topically applied medication may be high enough to produce unwanted local (rashes) or systemic side effects, while in other situations the uptake of compounds delivered as creams or gels may be lower than the effective level.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Other sources consider 500 Da as the limit

References

  1. Schäfer-Korting M, Mehnert W, Korting H-C (2007) Lipid nanoparticles for improved topical application of drugs for skin disease. Adv Drug Deliv Rev 59:427–443

    Article  PubMed  Google Scholar 

  2. Barry BW (2004) Breaching the skin’s barrier to drugs. Nat Biotechnol 22:165–167

    Article  CAS  PubMed  Google Scholar 

  3. Pardeike J, Hommoss A, Műller RH (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366:170–184

    Article  CAS  PubMed  Google Scholar 

  4. Mandawgade SD, Patravale VB (2008) Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 363:132–138

    Article  CAS  PubMed  Google Scholar 

  5. Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–196

    Article  CAS  PubMed  Google Scholar 

  6. Priano L, Esposti D, Castagna G, DeMedici C, Fraschini F, Gasco MR, Mauro A (2007) Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 7:3596–3601

    Article  CAS  PubMed  Google Scholar 

  7. Schubert MA, Műller-Goyman CC (2003) Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parameters. Eur J Pharm Biopharm 55:125–131

    Article  CAS  PubMed  Google Scholar 

  8. Heurtauld B, Saulnier P, Pech B, Proust JE, Benoit JP (2002) A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19:875–880

    Article  Google Scholar 

  9. Sjӧstrӧm B, Bergenstahl B (1992) Preparation of submicrom drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm 88:53–62

    Article  Google Scholar 

  10. Trotta M, Debernardi F, Caputo O (2003) Preparation of solid-lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 257:153–160

    Article  CAS  PubMed  Google Scholar 

  11. Puglia C, Blasi P, RizzaSchoubben A, Bonina F, Rossi C, Ricci M (2008) Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm 357:295–304

    Article  CAS  PubMed  Google Scholar 

  12. El-Harati AA, Charcosset C, Fessi H (2006) Influence of the formulation for solid lipid nanoparticles prepared with a membrane contractor. Pharm Dev Technol 11:153–157

    Article  CAS  PubMed  Google Scholar 

  13. Műller RH, Radtke M, Wissing SA (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54(Suppl 1):S131–S155

    Article  PubMed  Google Scholar 

  14. Schäfer-Korting M, Mehnert W (2005) Delivery of lipophilic compounds with lipid nanoparticles – applications in dermatics and for transdermal therapy. In: Nastruzzi C (ed) Drug targets and delivery: approach, methods, and applications. CRC Press, Boca Raton, pp 127–142

    Google Scholar 

  15. Mäder K (2005) Non-invasive spectroscopic and imaging techniques in drug delivery. Adv Drug Deliv Rev 57:1083–1084

    Article  Google Scholar 

  16. Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Rӧder B, Kramer KD, Schäfer-Korting M (2005) Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and paraelectric spectroscopy. J Control Release 110:151–163

    Article  CAS  PubMed  Google Scholar 

  17. Wissing SA, Kayser O, Műller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–1272

    Article  CAS  PubMed  Google Scholar 

  18. Shah KA, Date AA, Joshi MD, Patravale VB (2007) Solid lipid nanoparticles of tretinoin: potential in topical delivery. Int J Pharm 345:163–171

    Article  CAS  PubMed  Google Scholar 

  19. Wissing SA, Műller RH (2001) Solid lipid nanoparticles (SLN) – a novel carrier for UV blockers. Pharmazie 56:783–786

    CAS  PubMed  Google Scholar 

  20. Fang J-Y, Fang C-L, Liu C-H, Su Y-H (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70:633–640

    Article  CAS  PubMed  Google Scholar 

  21. Peddineni M, Tyrtova E, Balsara K, Komstead M, Benzecry A, Leonida MD (2013) Encapsulated lanthibiotics for longer shelf life of cosmetic formulations. In: Society of Cosmetic Chemists, Conference on technology transfer, Iselin, 13 November

    Google Scholar 

  22. Schwarz C, Mehnert W (1999) Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul 16:205–213

    Article  CAS  PubMed  Google Scholar 

  23. Santos Maia C, Mehnert W, Schaller H, Korting H, Gyler A, Haberland A, Schäfer-Korting M (2002) Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10:489–495

    Article  CAS  PubMed  Google Scholar 

  24. Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M (2004) Glucocorticoid entrapment into liquid carriers – characterization by paraelectric spectroscopy and influence on dermal uptake. J Control Release 97:493–502

    Article  CAS  PubMed  Google Scholar 

  25. Saupe A, Wissing SA, Lenk A, Schmidt C, Műller RH (2005) Solid lipid nanoparticles (SLN) and nanostructured carriers – structural investigations on two different carrier systems. Bio-Med Mater Eng 15:393–402

    CAS  Google Scholar 

  26. Műller RH, Petersen RD, Hommoss A, Pardeike J (2007) Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 59:522–530

    Article  PubMed  Google Scholar 

  27. Jenning V, Schäfer-Korting M, Gogla S (2000) Vitamin A loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 66:115–126

    Article  CAS  PubMed  Google Scholar 

  28. Műnster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis CC, Blume-Peytavi U, Schäfer-Korting M (2005) RU 58841-myristat- prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie 60:8–12

    PubMed  Google Scholar 

  29. Patel VB, Misra A, Marfatia YS (2000) Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm Dev Technol 5:455–464

    Article  CAS  PubMed  Google Scholar 

  30. Kalariya M, Padhi BK, Chougule M, Misra A (2005) Cobetasole propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. Indian J Exp Biol 43:233–240

    CAS  PubMed  Google Scholar 

  31. Ceve G, Blume G (2004) Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663:61–73

    Article  Google Scholar 

  32. Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603–618

    Article  CAS  PubMed  Google Scholar 

  33. Műller RH, Immig H, Hommoss A (2007) Prolonged release of perfumes by nanolipid technology (NLC). Eur Cosmet 11:12–18

    Google Scholar 

  34. Iscan Y, Wissing SA, Hekimoglu S, Műller RH (2005) Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drug N, N-diethylmethoxytoluamide and vitamin K. Pharmazie 60:905–909

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Leonida, M.D., Kumar, I. (2016). Lipid-Based Nanoparticles in Cosmetic and Pharmaceutical Products for the Skin. In: Bionanomaterials for Skin Regeneration. SpringerBriefs in Bioengineering. Springer, Cham. https://doi.org/10.1007/978-3-319-39168-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39168-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39166-3

  • Online ISBN: 978-3-319-39168-7

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics